MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD

NCT ID: NCT05194254

Last Updated: 2025-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-04

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Most studies use static visual percepts that are less representative of joint attention versus an ecological environment. This has the consequence of decreasing the perception of an interaction with a social partner, which is an essential step in achieving joint attention. The originality of this study is to improve the design of visual percepts (in the form of video) in order to mimic an ecological environment as much as possible by using MRI-ET coupling. The second originality of this study is the longitudinal exploration of the neurodevelopment of social cognition in autistic children. Studies by the Redcay and Oberwelland teams observe different activations at different ages. The hypothesis is that the perception of joint attention varies over time in people with ASD. To date, there are no studies to determine the influence of childhood neurodevelopment in autistic people on the perception of joint attention. It would be unprecedented to use the MRI-ET pairing as a tool for assessing social cognition as a function of the development of children with ASD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ASD Functional Magnetic Resonance Imaging Eye Tracking Social Cognition Joint Attention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ASD

people with Autism Spectrum Disorders

Group Type EXPERIMENTAL

MRI-ET

Intervention Type OTHER

coupled fMRI and Eye Tracking tools

TD

Typical Development) group of people

Group Type ACTIVE_COMPARATOR

MRI-ET

Intervention Type OTHER

coupled fMRI and Eye Tracking tools

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI-ET

coupled fMRI and Eye Tracking tools

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For the group of people with Autism Spectrum Disorders (experimental group):

* Age between 10 to 20 years old
* Diagnosis of ASD (CARS) ≥ 30 performed at inclusion
* IQ test evaluation (regardless of the result) performed by a trained psychologist
* Obtaining informed oral and written consent after appropriate information
* Obtaining informed oral and written consent from the legal guardian after information
* Be affiliated with social security
* No contraindication to magnetic resonance imaging

For the TD (Typical Development) group of people (control group):

* Age between 10 to 20 years old
* Diagnosis of ASD (CARS) \<30 performed at inclusion
* IQ test evaluation (regardless of the result) performed by a trained psychologist
* Obtaining informed oral and written consent after appropriate information
* Obtaining informed oral and written consent from the legal guardian after information
* Be affiliated with social security
* No contraindication to magnetic resonance imaging

Exclusion Criteria

For all groups:

* Age outside the range 10 to 20 years
* Person with a contraindication to MRI (including claustrophobia, pace maker, neurosurgical clips, vascular clips, heart valves, ventriculoperitoneal valves, cochlear implant, neurostimulator, intraocular metal shards, joint prosthesis, etc.)
* Person suffering from major obesity (\> 140 kg) not allowing him to enter the tunnel of the MRI machine (diameter \<70cm)
* Pregnant or breastfeeding woman
* Person under guardianship or guardianship or deprived of liberty by a judicial or administrative decision

For TD people (control group):

* Person with psychiatric disorders such as attention disorder with or without hyperactivity, depression, bipolar disorder and schizophrenia.
* Person with a neurological history such as epilepsy and / or neurovascular accident.
Minimum Eligible Age

10 Years

Maximum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens Picardie

Amiens, Picardie, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean-Marc Constans, Pr

Role: CONTACT

03 22 08 75 15

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jean-Marc CONSTANS, PhD

Role: primary

+33322087511

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI2021_843_0194

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Autistic Eye Contact?
NCT06921876 COMPLETED
Radiomics of Autism Spectrum Disorder
NCT05439954 ACTIVE_NOT_RECRUITING